Clinical Trial Update: A Comparative Study of KES524 in Patients With Obesity Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of KES524 in obesity has completed; outcomes are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• KES524 (KES524)

Snippet

Sponsor: Eisai Limited | Conditions: Obesity | Phase 3 | Status: COMPLETED